🇺🇸 FDA
Patent

US 11859190

Methods and compositions for regulation of transgene expression

granted A61PA61P1/16A61P11/00

Quick answer

US patent 11859190 (Methods and compositions for regulation of transgene expression) held by Sangamo Therapeutics, Inc. expires Mon Dec 28 2043 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
Sangamo Therapeutics, Inc.
Grant date
Tue Jan 02 2024 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Dec 28 2043 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
5
CPC classes
A61P, A61P1/16, A61P11/00, A61P17/00, A61P3/00